NCT Number: NCT07431411
Ectopic pregnancy (EP) is defined as the implantation of a fertilized ovum outside the uterine cavity, most commonly in the fallopian tubes. EP is a potentially life-threatening condition due to the risk of tubal rupture and intra-abdominal bleeding. Management of ectopic pregnancy may involve medical or surgical treatment, often requiring hospitalization.
Following treatment and discharge, women may experience physical, emotional, and sexual health challenges. In addition, the need for effective contraception after ectopic pregnancy treatment is critical due to the risk of recurrent ectopic pregnancy and the potential teratogenic effects of treatment agents such as methotrexate. However, limited data are available regarding contraceptive intentions and sexual quality of life after ectopic pregnancy treatment in Türkiye.
This study aims to evaluate contraceptive intention and sexual quality of life in women treated for ectopic pregnancy and to examine the relationship between length of hospital stay, contraceptive intention, and sexual quality of life. Data will be collected using the Participant Information Form, the Contraceptive Intention Scale (CIS), and the Sexual Life Quality Scale-Women (SLQS-W). In addition, a reproductive health educational brochure will be provided to participants as part of post-treatment counseling.
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
This study is a randomized controlled trial conducted among women diagnosed with ectopic pregnancy who have completed medical or surgical treatment. Eligible participants are women aged 18 years and older who are clinically stable at the time of discharge.
Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive standard post-treatment care in addition to structured reproductive health counseling supported by an educational brochure addressing contraception and sexual health after ectopic pregnancy. The control group will receive standard post-treatment care only.
Data will be collected at baseline and at follow-up using validated instruments. Sociodemographic and clinical characteristics will be obtained using the Participant Information Form. Contraceptive intention will be assessed using the Contraceptive Intention Scale (CIS), and sexual quality of life will be evaluated using the Sexual Life Quality Scale-Women (SLQS-W).
Length of hospital stay and treatment characteristics will be recorded. The primary outcomes of the study are contraceptive intention and sexual quality of life. The relationship between length of hospital stay, contraceptive intention, and sexual quality of life will be analyzed between the intervention and control groups.
Participation is voluntary, and written informed consent will be obtained from all participants prior to enrollment. The study has received ethical approval from the Ege University Medical Research Ethics Committee.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Structured reproductive health counseling focusing on contraception and sexual health after ectopic pregnancy, supported by an educational brochure provided after completion of medical or surgical treatment.
Time frame: Baseline (at discharge) and 1 month after intervention
Contraceptive intention will be assessed using the Contraceptive Intention Scale (CIS), which measures women's intention to use effective contraception after ectopic pregnancy treatment.
Contact information is provided by the study sponsor or research team.
Buket Kömürcü
Other
The Effect of Reproductive Health Education on Contraceptive Method Use Intention and Sexual Life Quality of Women Diagnosed With Ectopic Pregnancy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07624903
Ectopic Pregnancy, Female Urogenital Diseases and Pregnancy Complications
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
View Trial DetailsNCT07009808
Anxiety, Anxiety Disorders
View Trial DetailsNCT06721403
Ectopic Pregnancy, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT06554964
Ectopic Pregnancy, Female Urogenital Diseases and Pregnancy Complications
View Trial Details